|
COPB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.69169999999897E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.157800E-04 |
| Normal-vs-Stage2 |
1.455600E-01 |
| Normal-vs-Stage3 |
1.85388999999203E-05 |
| Normal-vs-Stage4 |
8.436700E-03 |
| Stage1-vs-Stage2 |
3.770800E-01 |
| Stage1-vs-Stage3 |
6.730100E-02 |
| Stage1-vs-Stage4 |
7.666800E-01 |
| Stage2-vs-Stage3 |
5.171800E-02 |
| Stage2-vs-Stage4 |
3.727000E-01 |
| Stage3-vs-Stage4 |
3.215400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.950210E-04 |
| Normal-vs-AfricanAmerican |
1.09739999998304E-06 |
| Normal-vs-Asian |
1.432570E-01 |
| Caucasian-vs-AfricanAmerican |
2.114400E-02 |
| Caucasian-vs-Asian |
9.388400E-01 |
| AfricanAmerican-vs-Asian |
3.587400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72349999999488E-05 |
| Normal-vs-Female |
5.024800E-03 |
| Male-vs-Female |
9.041500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.101050E-03 |
| Normal-vs-Age(41-60Yrs) |
8.774100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.795700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.672440E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.359400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.068600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.748000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.561600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.691000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.339200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.225600E-01 |
| Normal-vs-Grade 2 |
4.575300E-03 |
| Normal-vs-Grade 3 |
3.69479999999811E-05 |
| Normal-vs-Grade 4 |
3.210300E-04 |
| Grade 1-vs-Grade 2 |
5.307600E-01 |
| Grade 1-vs-Grade 3 |
2.589600E-01 |
| Grade 1-vs-Grade 4 |
2.142200E-01 |
| Grade 2-vs-Grade 3 |
1.378230E-01 |
| Grade 2-vs-Grade 4 |
8.964300E-02 |
| Grade 3-vs-Grade 4 |
4.262000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.364100E-02 |
| Normal-vs-ccB subtype |
1.72997999999813E-05 |
| ccA subtype-vs-ccB subtype |
7.435700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.301770E-03 |
| Normal-vs-N1 |
1.191180E-01 |
| N0-vs-N1 |
5.907000E-01 |
|
|
